{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:30:03Z","timestamp":1791462603440,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":4297,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.ymthe.2004.09.017","type":"journal-article","created":{"date-parts":[[2004,11,4]],"date-time":"2004-11-04T18:28:44Z","timestamp":1099592924000},"page":"48-56","source":"Crossref","is-referenced-by-count":120,"title":["Replacing acid \u03b1-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers"],"prefix":"10.1016","volume":"11","author":[{"given":"Nina","family":"Raben","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokiko","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail L.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth L.","family":"Thurberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Mattaliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Meikle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Hopwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanneboyina","family":"Nagaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H.","family":"Plotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2004.09.017_bib1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature","volume":"112","author":"Van den Hout","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymthe.2004.09.017_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1067\/mpd.2000.107112","article-title":"Identification of two subtypes of infantile acid maltase deficiency","volume":"137","author":"Slonim","year":"2000","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymthe.2004.09.017_bib3","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"3389","author":"Hirschhorn","year":"2000"},{"key":"10.1016\/j.ymthe.2004.09.017_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1566524024605789","article-title":"Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease)","volume":"2","author":"Raben","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ymthe.2004.09.017_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.bi.61.070192.001515","article-title":"Structure and function of the mannose 6-phosphate\/insulinlike growth factor II receptors","volume":"61","author":"Kornfeld","year":"1992","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2004.09.017_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0304-4157(95)00004-B","article-title":"Mannose 6-phosphate receptors in sorting and transport of lysosomal enzymes","volume":"1241","author":"Hille-Rehfeld","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2004.09.017_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0167-4889(98)00057-3","article-title":"Protein transport from the secretory to the endocytic pathway in mammalian cells","volume":"1404","author":"Le Borgne","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2004.09.017_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrm1050","article-title":"Mannose 6-phosphate receptors: new twists in the tale","volume":"4","author":"Ghosh","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2004.09.017_bib9","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/j.1460-2075.1988.tb02998.x","article-title":"Primary structure and processing of lysosomal alpha-glucosidase: homology with the intestinal sucrase\u2013isomaltase complex","volume":"7","author":"Hoefsloot","year":"1988","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2004.09.017_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1042\/bj2720485","article-title":"Expression and routing of human lysosomal alpha-glucosidase in transiently transfected mammalian cells","volume":"272","author":"Hoefsloot","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymthe.2004.09.017_bib11","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0021-9258(18)53985-5","article-title":"Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation","volume":"268","author":"Wisselaar","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2004.09.017_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","article-title":"Recombinant human alpha-glucosidase from rabbit milk in Pompe patients","volume":"356","author":"Van den Hout","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2004.09.017_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1023\/A:1010383421286","article-title":"Enzyme therapy for Pompe disease with recombinant human alpha-glucosidase from rabbit milk","volume":"24","author":"Van den Hout","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2004.09.017_bib14","first-page":"132","article-title":"Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano","year":"2001","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2004.09.017_bib15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/mus.10381","article-title":"Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy","volume":"27","author":"Winkel","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2004.09.017_bib16","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk","volume":"113","author":"Van den Hout","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymthe.2004.09.017_bib17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20019","article-title":"Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up","volume":"55","author":"Winkel","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2004.09.017_bib18","series-title":"Proceedings of the International Pompe Conference","first-page":"30","article-title":"Duke experience","author":"Kishnani","year":"2003"},{"key":"10.1016\/j.ymthe.2004.09.017_bib19","series-title":"Proceedings of the International Pompe Conference","first-page":"29","article-title":"Rotterdam experience with enzyme replacement therapy for Pompe's disease","author":"Van der Ploeg","year":"2003"},{"key":"10.1016\/j.ymthe.2004.09.017_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2004.09.017_bib21","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/hmg\/10.19.2039","article-title":"Conditional tissue-specific expression of the acid alpha-glucosidase (GAA) gene in the GAA knockout mice: implications for therapy","volume":"10","author":"Raben","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2004.09.017_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1022998010833","article-title":"Induction of tolerance to a recombinant human enzyme, acid alpha-glucosidase, in enzyme deficient knockout mice","volume":"12","author":"Raben","year":"2003","journal-title":"Transgenic Res."},{"key":"10.1016\/j.ymthe.2004.09.017_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jmor.1052210207","article-title":"Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb","volume":"221","author":"Burkholder","year":"1994","journal-title":"J. Morphol."},{"key":"10.1016\/j.ymthe.2004.09.017_bib24","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1242\/jcs.108.8.2865","article-title":"Expression and localization of alpha-adaptin isoforms","volume":"108","author":"Ball","year":"1995","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ymthe.2004.09.017_bib25","first-page":"1533","article-title":"Acid maltase deficiency","volume":"Vol. 2","author":"Engel","year":"1994"},{"key":"10.1016\/j.ymthe.2004.09.017_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.bi.60.070191.001353","article-title":"Lysosomal storage diseases","volume":"60","author":"Neufeld","year":"1991","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2004.09.017_bib27","first-page":"9","article-title":"Lysosomal storage diseases market","volume":"3","author":"Werber","year":"2004","journal-title":"Nat. Rev."},{"key":"10.1016\/j.ymthe.2004.09.017_bib28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1203\/00006450-198807000-00021","article-title":"Receptor-mediated uptake of acid alpha-glucosidase corrects lysosomal glycogen storage in cultured skeletal muscle","volume":"24","author":"Van der Ploeg","year":"1988","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymthe.2004.09.017_bib29","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1172\/JCI115025","article-title":"Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice","volume":"87","author":"Van der Ploeg","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2004.09.017_bib30","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1089\/hum.1997.8.13-1555","article-title":"Retroviral transfer of acid alpha-glucosidase cDNA to enzyme-deficient myoblasts results in phenotypic spread of the genotypic correction by both secretion and fusion","volume":"8","author":"Zaretsky","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.09.017_bib31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1525-0016(02)90716-1","article-title":"Glycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme","volume":"6","author":"Raben","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.09.017_bib32","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1073\/pnas.96.16.8861","article-title":"Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase","volume":"96","author":"Amalfitano","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.09.017_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1525-0016(02)00055-2","article-title":"Long-term correction of glycogen storage disease type II with a hybrid Ad-AAV vector","volume":"7","author":"Sun","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.09.017_bib34","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1006\/mthe.2002.0563","article-title":"Efficacy of gene therapy for a prototypical lysosomal storage disease (GSD-II) is critically dependent on vector dose, transgene promoter, and the tissues targeted for vector transduction","volume":"5","author":"Ding","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.09.017_bib35","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1089\/104303401750195917","article-title":"Long-term efficacy after [E1\u2212, polymerase\u2212] adenovirus-mediated transfer of human acid-alpha-glucosidase gene into glycogen storage disease type II knockout mice","volume":"12","author":"Ding","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.09.017_bib36","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1006\/mthe.2002.0580","article-title":"Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors","volume":"5","author":"Fraites","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.09.017_bib37","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/hmg\/8.12.2145","article-title":"Human acid alpha-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II","volume":"8","author":"Bijvoet","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2004.09.017_bib38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev.biochem.66.1.511","article-title":"Clathrin-coated vesicle formation and protein sorting: an integrated process","volume":"66","author":"Schmid","year":"1997","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2004.09.017_bib39","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1146\/annurev.biochem.69.1.699","volume":"69","author":"Kirchhausen","year":"2000","journal-title":"Clathrin. Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2004.09.017_bib40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev.cellbio.17.1.517","article-title":"Biological basket weaving: formation and function of clathrin-coated vesicles","volume":"17","author":"Brodsky","year":"2001","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2004.09.017_bib41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0092-8674(02)00751-1","article-title":"Clathrin adaptors really adapt","volume":"109","author":"Kirchhausen","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2004.09.017_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature01451","article-title":"Regulated portals of entry into the cell","volume":"422","author":"Conner","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2004.09.017_bib43","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0092-8674(02)00735-3","article-title":"Molecular architecture and functional model of the endocytic AP2 complex","volume":"109","author":"Collins","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2004.09.017_bib44","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0955-0674(00)00235-0","article-title":"Adaptor-related proteins","volume":"13","author":"Robinson","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ymthe.2004.09.017_bib45","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1083\/jcb.200305145","article-title":"Clathrin-mediated endocytosis in AP-2-depleted cells","volume":"162","author":"Motley","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymthe.2004.09.017_bib46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1247\/csf.27.401","article-title":"Toward and beyond lysosomes","volume":"27","author":"Yoshimori","year":"2002","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.ymthe.2004.09.017_bib47","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.bbrc.2003.07.023","article-title":"Autophagy: a regulated bulk degradation process inside cells","volume":"313","author":"Yoshimori","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymthe.2004.09.017_bib48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.136.1.61","article-title":"The autophagic and endocytic pathways converge at the nascent autophagic vacuoles","volume":"136","author":"Liou","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymthe.2004.09.017_bib49","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.cr.7290023","article-title":"The convergent point of the endocytic and autophagic pathways in Leydig cells","volume":"9","author":"Jing","year":"1999","journal-title":"Cell Res."},{"key":"10.1016\/j.ymthe.2004.09.017_bib50","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11910-003-0040-y","article-title":"Autophagic vacuolar myopathies","volume":"3","author":"Nishino","year":"2003","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.ymthe.2004.09.017_bib51","first-page":"250","article-title":"Acid maltase deficiency of adult life","volume":"94","author":"Engel","year":"1969","journal-title":"Trans. Am. Neurol. Assoc."},{"key":"10.1016\/j.ymthe.2004.09.017_bib52","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/brain\/93.3.599","article-title":"Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies","volume":"93","author":"Engel","year":"1970","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2004.09.017_bib53","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/jnnp.47.2.213","article-title":"Myopathy due to juvenile acid maltase deficiency affecting exclusively the type I fibres","volume":"47","author":"Papapetropoulos","year":"1984","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymthe.2004.09.017_bib54","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.410010314","article-title":"The adult form of acid maltase (alpha-1,4-glucosidase) deficiency","volume":"1","author":"Karpati","year":"1977","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2004.09.017_bib55","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1124\/mol.54.3.495","article-title":"Transgenic animals with inducible, targeted gene expression in brain","volume":"54","author":"Chen","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ymthe.2004.09.017_bib56","first-page":"132","article-title":"Biochemical, immunological, and cell genetic studies in glycogenosis type II","volume":"30","author":"Reuser","year":"1978","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2004.09.017_bib57","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/clinchem\/47.8.1378","article-title":"Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease","volume":"47","author":"Umapathysivam","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymthe.2004.09.017_bib58","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1172\/JCI1722","article-title":"Clinical and metabolic correction of Pompe disease by enzyme therapy in acid maltase-deficient quail","volume":"101","author":"Kikuchi","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2004.09.017_bib59","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1212\/WNL.56.12.1739","article-title":"Surprises of genetic engineering: a possible model of polyglucosan body disease","volume":"56","author":"Raben","year":"2001","journal-title":"Neurology"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604014686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604014686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T17:30:45Z","timestamp":1624815045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001604014686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S1525001604014686"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2004.09.017","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}